With this acquisition, VERTEBRON's portfolio will address an even greater range of pathologies and treatment options including, but not limited to circumferential and anterior thoracolumbar fusion. VERTEBRON is also planning on future product releases including additional biologic (Anterior Cervical Fusion (ACF) allograft) and radiolucent interbody products, and motion preservation devices for both the cervical and lumbar spine.
Dr. Robert Dixon, at Grant Medical Center, a renowned trauma center in Columbus, OH, commented, "In addition to VERTEBRON's rapid entry into many segments of spinal surgery, their technology base and design approach toward innovative, easy to use spinal implants is quite impressive from both a surgical and technical standpoint." Hosam Afifi, President and CEO of VERTEBRON added, "This recent acquisition of strategic patents will greatly add to and compliment VERTEBRON's broad product and technology portfolio. We are confident that this addition will greatly enhance future designs and provide immediate clinical benefits, including lower profile plating systems and locking mechanisms for both the cervical and anterior thoracolumbar spine."
VERTEBRON is a closely-held, medical device company that has developed spinal implants, including artificial discs (motion preservation), cervical plates, pedicle screw and interbody (fusion) systems through the integration of spinal, orthopaedic and total joint technologies. VERTEBRON's advanced motion preservation devices, fusion technologies and breakthrough spinal implant designs are strategically positioned to establish the company as a leading provider of next-generation spinal surgery solutions. VERTEBRON's comprehensive product portfolio offers simplified surgical techniques, enhanced intra-operative flexibility and innovative instrumentation to spine surgeons worldwide. For more information, please visit www.VERTEBRON.com.
Any statements in this press release about future expectations, plans and prospects for the Company, including statements containing the words "believes," "anticipates," "plans," "expects," "will," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various factors, risks and uncertainties. These statements are subject to change based on risks detailed from time to time in VERTEBRON's Business Plan and stock offering documents and other known and unknown risks and factors, which could cause the actual results or performance to differ materially from the statements made. Do not place undue reliance on forward-looking statements, which reflect our analysis only and speak only as of the date hereof.